Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone in COVID-19 pneumonia
IRCT20200317046797N6Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of edaravone in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Symptoms of the disease, Mortality rate and 1 more. Started Dec 2020; status: completed.
02
Drugs
edaravone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200317046797N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200317046797N6.